Join
Live feed
·
INSIDERFilingvia Quantisnow
Vertex Pharmaceuticals Incorporated logo

EVP and CMO Bozic Carmen sold $3,144,600 worth of shares (6,988 units at $450.00) as part of a pre-agreed trading plan, decreasing direct ownership by 21% to 26,088 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VRTX (Vertex Pharmaceuticals Incorporated) and more on Quantisnow.